Bruce McCreedy,Timothy David Jones,Francis Joseph Carr
申请号：
US15937302
公开号：
US20180214564A1
申请日:
2018.03.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes for presentation of an antigen (e.g., a tumor antigen) and/or a T cell co-stimulatory molecule.
